Girgert R,Emons G,Gründker C.Inactivation of GPR30reduces growth of triple-negative breast cancer cells:possible application in targeted therapy[J].Breast Cancer Res Treat,2012,134(1):199-205.
[2]
Meliou E,Kerezoudis NP,Tosios KI,et al.Notch 1receptor,delta 1ligand and HES 1transcription factor are expressed in the lining epithelium of periapical cysts(preliminary study)[J].Open Dent J,2010,4:153-158.
Lamb R,Ablett MP,Spence K,et al.Wnt pathway activity in breast cancer sub-types and stem-like cells[J].PLoS One,2013,8(7):e67811.
[5]
Dellinger TH,Planutis K,Tewari KS,et al.Role of canonical Wnt signaling in endometrial carcinogenesis[J].Expert Rev Anticancer Ther,2012,12(1):51-62.
[6]
Sturrock M,Hellander A,Matzavinos A,et al.Spatial stochastic modelling of the Hes1gene regulatory network:intrinsic noise can explain heterogeneity in embryonic stem cell differen tiation[J].J R Soc Interface,2013,10(80):20120988.
[7]
Espinoza I,Pochampally R,Xing F,et al.Notch signaling:targeting cancer stem cells and epithelial-tomesenchymal transition[J].Onco Targets and Therapy,2013,6:1 249-1 259.
Carre A,Rachdi L,Tron E,et al.Hes1is required for appropriate morphogenesis and differentiation during mouse thyroid gland development[J].PLoS One,2011,6(2):e16752.
[10]
Dailey DD,Anfinsen KP,Pfaff LE,et al.HES1,a target of Notch signaling,is elevated in canine osteosarcoma,but reduced in the most aggressive tumors[J].BMC Vet Res,2013,9:130.
[11]
Guillemette C,Bélanger,Lépine J.Metabolic inactivation of estrogens in breast tissue by UDP-glucuronosyltransferase enzymes:an overview[J].Breast Cancer Res,2004,6(6):246-254.
[12]
Zhou M,Yan J,Ma Z,et al.Comparative and Evolutionary Analysis of the HES/HEY Gene Family Reveal Exon/Intron Loss and Teleost Specific Duplication Events[J].PLoS One,2012,7(7):e406492012.
Wei Y,Zhang Z,Liao H,et al.Nuclear estrogen receptor-mediated Notch signaling and GPR30-mediated PI3K/AKT signaling in the regulation of endometrial cancer cell proliferation[J].Oncol Rep,2012,27(2):504-510.
[15]
Janzen DM,Paik DY,Rosales MA,et al.Low levels of circulating estrogen sensitize PTEN-Null endometrial tumors to PARP inhibition in vivo[J].Mol Cancer Ther,2013,12(12):2 917-2 928.
